I was thinking of buying a Cripr call for Monday for $46. The current price is $44. My target is about $50.
It fell 10% over the weekend because Crispr is aiming to dilute shares to raise capital for an upcoming Trial. This is really good news. Their US trial is on hold but their Europe trials are recruiting and going forward.
I bought this stock a few months ago at $44. and it has stayed over $50 since then. pretty much the whole time.
I went with $46 because the options closer to the stock price were a little more expensive so i assumed the upside was not as great. I have never bought an option before So i just want to make sure I am doing this right.
I plan to sell on Monday at some point. Or whenever it hits around $50...if that happens.
Submitted September 22, 2018 at 07:10PM by HunterRountree https://ift.tt/2MVPbeO
No comments:
Post a Comment